Literature DB >> 25687911

Gynaecological cancer: Survival benefit and quality of life.

Lisa Hutchinson.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25687911     DOI： 10.1038/nrclinonc.2015.27

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).

Authors:  Richard T Penson; Helen Q Huang; Lari B Wenzel; Bradley J Monk; Sharon Stockman; Harry J Long; Lois M Ramondetta; Lisa M Landrum; Ana Oaknin; Thomas J A Reid; Mario M Leitao; Michael Method; Helen Michael; Krishnansu S Tewari
Journal:  Lancet Oncol       Date:  2015-01-29       Impact factor: 41.316
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.